Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Frederick M. Quitkin"'
Autor:
Roy H. Perlis, Frederick M. Quitkin, Deborah L. Shear, Jerrold F. Rosenbaum, Charles M. Beasley, Roy N. Tamura, James D. Wines, Cristina Cusin, Maurizio Fava, Robert E. Strong, Jay D. Amsterdam
Publikováno v:
Psychotherapy and Psychosomatics. 76:40-46
Background: Some reports suggest that a subset of depressed patients may experience suicidality – that is increase or emergence of suicidal ideation (SI) or behavior – after initiation of an antidepressant. The time course and clinical correlates
Autor:
Jerrold F. Rosenbaum, Jay D. Amsterdam, Jan Fawcett, Charles M. Beasley, Frederick W. Reimherr, Frederick M. Quitkin, Felipe Garcia-Espana
Publikováno v:
Journal of Clinical Psychopharmacology. 19:9-14
Recent reports of sustained hypertension in some patients receiving venlafaxine have rekindled concerns about antidepressant-induced hypertension. This study examined sitting and standing systolic and diastolic blood pressure, pulse rate, and rate of
Autor:
Frederick W. Reimherr, Charles M. Beasley, Jerrold F. Rosenbaum, Edward Schweizer, Felipe Garcia-Espana, Jay D. Amsterdam, Jan Fawcett, Frederick M. Quitkin
Publikováno v:
Journal of Clinical Psychopharmacology. 18:435-440
As many as 45% of patients with major depressive episode also meet DSM-IV criteria for bipolar II (BP II) disorder. Although some clinicians advocate using a mood stabilizer in treating BP II depression, antidepressant monotherapy has been less well
Autor:
Michael E. Thase, Maurizio Fava, Louise Ritz, Kathy Shores-Wilson, Frederick M. Quitkin, Diane Warden, A. John Rush, Melanie M. Biggs, James F. Luther, Andrew A. Nierenberg, Barry D. Lebowitz, Madhukar H. Trivedi, Stephen R. Wisniewski
Publikováno v:
The New England journal of medicine. 354(12)
Although clinicians frequently add a second medication to an initial, ineffective antidepressant drug, no randomized controlled trial has compared the efficacy of this approach.We randomly assigned 565 adult outpatients who had nonpsychotic major dep
Publikováno v:
Journal of clinical psychopharmacology. 22(4)
One reason for failure to find specific treatment effects in drug versus placebo trials with patients who have depression is an insufficient period of observation. Also, differentiating between early fleeting response and maintained response has been
Publikováno v:
American Journal of Psychiatry. 158:1332
Autor:
Jonathan W. Stewart, Wilma Harrison, Donald F. Klein, Michael R. Liebowitz, Patrick J. McGrath, Frederick M. Quitkin
Publikováno v:
Journal of Clinical Psychopharmacology. 3:257
Autor:
Edward V. Nunes, Judith G. Rabkin, Wilma Harrison, Donald F. Klein, Jonathan W. Stewart, Tricamo E, Steven Wager, John S. Markowitz, McGrath Pj, Frederick M. Quitkin
Publikováno v:
Archives of General Psychiatry. 46:787
Sixty patients who met Research Diagnostic Criteria for major, intermittent, or minor depressive disorder and had reactive mood without atypical symptoms were treated with imipramine hydrochloride, phenelzine sulfate, or a placebo. These patients, re